Press enter to begin your search

Open Orphan - Investment Case

ORPH
Thu, 10 Oct 2019, 07:00 BST

What is Open Orphan's strategy? Why is it so attractive to shareholders? Cathal Friel provides a short summary of the investment proposition.

Cathal Friel
CEO
ORPH
5d975c2ff8cc7162f3b02db0
SHOW MORE
FROM THIS COMPANY
Open Orphan - Investment Case
ORPH Thu, 10 Oct 2019, 07:00 BST

Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug-focused pharma services company by a management team with extensive industry and financial expertise.

Industry: Health Care

Contact: +353 (01) 6440007
Dublin 2, Ireland
https://www.openorphan.com

What is Open Orphan's strategy? Why is it so attractive to shareholders? Cathal Friel provides a short summary of the investment proposition.

Cathal Friel
CEO
POWERED BY